Improving vascular health: Are pills the answer?

BMJ (Online)

Volumn 344, Issue 7860, 2012, Pages

  Smeeth, Liam ^a   Hemingway, Harry ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ATTITUDE TO HEALTH; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DRUG COST; DRUG RESEARCH; DRUG USE; EDITORIAL; HEALTH CARE ACCESS; HUMAN; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MYOPATHY; NEOPLASM; PATIENT EDUCATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RHABDOMYOLYSIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; RISK FACTOR;

CARDIOVASCULAR DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 84862132081     PISSN: 17561833     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.e3802     Document Type: Editorial

References (10)

1. National Institute for Health and Clinical Excellence. Lipid modification. CG67. 2010. www. nice.org.uk/CG67.
2. National Heart Lung and Blood Institute. ATP III update 2004. www.nhlbi.nih.gov/guidelines/ cholesterol/atp3upd04.htm.
3. Perk J, De Backer G, Gohlke H, Graham I, Reiner Ž, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; published online 3 May. http://eurheartj.oxfordjournals.org/cgi/doi/10.1093/eurheartj/ehs092.
4. Cholesterol Treatment Trialists' Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012; published online 17 May.
5. Jackevicius CA, Chou MM, Ross JS, Shah ND, Krumholz HM. Generic atorvastatin and health care costs. N Engl J Med 2012;366:201-4.
6. Armitage J. The safety of statins in clinical practice. Lancet 2007;370;1781-90. (Pubitemid 350137473)
7. Smeeth L, Douglas I, Hall AJ, Hubbard R, Evans S. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol 2009;67:99-109.
8. Goldfine AB. Statins: is it really time to reassess benefits and risks? N Engl J Med 2012;366:1752-5.
9. Heart Protection Study Collaborative Group, Bulbulia R, Bowman L, Wallendszus K, Parish S, Armitage J, Peto R, et al. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Lancet 2011;378:2013-20.
10. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-70. (Pubitemid 24267213)